Kimmtrak will now be available on the NHS in England to treat HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, with more than 100 patients expected to be eligible for the drug every year.
Uveal melanoma is a rare and aggressive form of melanoma affecting the eye, with up to 50% of patients eventually developing metastatic disease. Unresectable or metastatic uveal melanoma typically has a poor prognosis and, until now, had no approved treatment…
